CH311612A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents

Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Info

Publication number
CH311612A
CH311612A CH311612DA CH311612A CH 311612 A CH311612 A CH 311612A CH 311612D A CH311612D A CH 311612DA CH 311612 A CH311612 A CH 311612A
Authority
CH
Switzerland
Prior art keywords
anilide
methyl
cyclohexylamine
chloro
halogen
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Cilag
Original Assignee
Cilag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag filed Critical Cilag Ag
Publication of CH311612A publication Critical patent/CH311612A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Description

  

  



  Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure   (2-halogen-6-methyl-anilids).   



   Gegenstand des vorliegenden Patentes bilclet ein Verfahren zur Herstellung eines neuen basisch   substituierten Fet$säure- (Whalegen-6-       methyl-anilids), welches dadurch gekennzeich-    net ist, dass man eine Verbindung der Formel
EMI1.1     
 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Cyclohexylamin umsetzt.



   Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austa. usch gegen den   basisehen    Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy- oder Arylsulfonyloxygruppe, bestehen. Der   Austauseh    der Gruppe X gegen den   Cyclohexylaminrest erfolgt z.    B. durch einfaches Erwärmen mit Cyclohexylamin gege  benenfalls    in Gegenwart eines basisch reagie  renden Kondensationsmittels    oder von Cyclohexylamin im Überschuss. Das Cyclohexyl  amino-acet-    (2-chlor-6-methyl-anilid) ist ein farbloses   61.    Das Hydrochlorid der Base schmilzt bei   231-233 .   



   Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.



   Beispiel:
36 Gewichtsteile   Chloracet-      (2-chlor-6-me-       th, vl-anilid) (gewonnen dureh ITmsetzen von    2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis   141 )    werden in 80 Gewichtsteilen Äthanol suspendiert und mit 50 Gewichtsteilen Cyclohexylamin   verset. zt.    Die Temperatur steigt dabei leicht an und ein grosser Teil des   Reak-    tionsgemisehes geht in   Losung.    Nun wird wÏhrend 4 Stunden bei Zimmertemperatur ge  riihrt    und dann einige Stunden bei Siedetemperatur.

   Mit Wasserdampf wird hierauf der Alkohol und das   überschüssige Cyclohexyl-    a. min abgeblasen und naeh dem Erkalten das zurückbleibende Öl in Äther aufgenommen.



  Nach dem Trocknen der ätherisehen Lösung und Verjagen des   Losungsmittels    verbleibt ein   Öl,    das durch Überführen in das Hydrochlorid gereinigt wird. Man erhält 30 Ge  wichtsteile    reines   Cyclohexylamino-acet-    (2  chlor-6-methyl-anilid).    Die Umsetzung mit   Cyelohexylamin kann auch    in Benzol stattfinden.  



   PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basisch substituierten   Fettsäure-      (2-halogen-6-       methyl-anilids), dadurch gekennzeiehnet, dass    man eine Verbindung der Formel
EMI1.2     
 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).



   The subject of the present patent is a process for the production of a new basic substituted fatty acid (Whalegen-6-methyl-anilide) which is characterized in that a compound of the formula
EMI1.1
 in which X is a reactive radical which is split off during the reaction, reacts with cyclohexylamine.



   The radical X can be in a halogen atom or another for the Austa. usch against the basic radical suitable reactive substituents, such as. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the cyclohexylamine radical takes place z. B. by simply heating with cyclohexylamine, if necessary, in the presence of a basic reacting condensing agent or of cyclohexylamine in excess. The cyclohexylamino-acet- (2-chloro-6-methyl-anilide) is a colorless 61. The hydrochloride of the base melts at 231-233.



   The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.



   Example:
36 parts by weight of chloroacet- (2-chloro-6-meth, vl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are added in 80 parts by weight Suspended ethanol and mixed with 50 parts by weight of cyclohexylamine. nt. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at boiling temperature.

   The alcohol and the excess cyclohexyl-a are then removed with steam. min blown off and after cooling the remaining oil absorbed in ether.



  After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by converting it into the hydrochloride. 30 parts by weight of pure cyclohexylamino-acet- (2 chloro-6-methyl-anilide) are obtained. The reaction with cyelohexylamine can also take place in benzene.



   PATENT CLAIM:
Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula
EMI1.2
 in which X is a reactive radical that is split off during the reaction,

** WARNING ** End of DESC field could overlap beginning of CLMS **.



 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines neuen basisch substituierten FettsÏure (2-halogen-6-methyl-anilids). Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). Gegenstand des vorliegenden Patentes bilclet ein Verfahren zur Herstellung eines neuen basisch substituierten Fet$säure- (Whalegen-6- methyl-anilids), welches dadurch gekennzeich- net ist, dass man eine Verbindung der Formel EMI1.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit Cyclohexylamin umsetzt. The subject of the present patent is a process for the production of a new basic substituted fatty acid (Whalegen-6-methyl-anilide) which is characterized in that a compound of the formula EMI1.1 in which X is a reactive radical which is split off during the reaction, reacts with cyclohexylamine. Der Rest X kann in einem Halogenatom oder einem sonstigen für den Austa. usch gegen den basisehen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy- oder Arylsulfonyloxygruppe, bestehen. Der Austauseh der Gruppe X gegen den Cyclohexylaminrest erfolgt z. B. durch einfaches Erwärmen mit Cyclohexylamin gege benenfalls in Gegenwart eines basisch reagie renden Kondensationsmittels oder von Cyclohexylamin im Überschuss. Das Cyclohexyl amino-acet- (2-chlor-6-methyl-anilid) ist ein farbloses 61. Das Hydrochlorid der Base schmilzt bei 231-233 . The radical X can be in a halogen atom or another for the Austa. usch against the basic radical suitable reactive substituents, such as. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the cyclohexylamine radical takes place z. B. by simply heating with cyclohexylamine, if necessary, in the presence of a basic reacting condensing agent or of cyclohexylamine in excess. The cyclohexylamino-acet- (2-chloro-6-methyl-anilide) is a colorless 61. The hydrochloride of the base melts at 231-233. Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden. The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives. Beispiel: 36 Gewichtsteile Chloracet- (2-chlor-6-me- th, vl-anilid) (gewonnen dureh ITmsetzen von 2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 80 Gewichtsteilen Äthanol suspendiert und mit 50 Gewichtsteilen Cyclohexylamin verset. zt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Reak- tionsgemisehes geht in Losung. Nun wird wÏhrend 4 Stunden bei Zimmertemperatur ge riihrt und dann einige Stunden bei Siedetemperatur. Example: 36 parts by weight of chloroacet- (2-chloro-6-meth, vl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are added in 80 parts by weight Suspended ethanol and mixed with 50 parts by weight of cyclohexylamine. nt. The temperature rises slightly and a large part of the reaction mixture goes into solution. The mixture is then stirred for 4 hours at room temperature and then for a few hours at boiling temperature. Mit Wasserdampf wird hierauf der Alkohol und das überschüssige Cyclohexyl- a. min abgeblasen und naeh dem Erkalten das zurückbleibende Öl in Äther aufgenommen. The alcohol and the excess cyclohexyl-a are then removed with steam. min blown off and after cooling the remaining oil absorbed in ether. Nach dem Trocknen der ätherisehen Lösung und Verjagen des Losungsmittels verbleibt ein Öl, das durch Überführen in das Hydrochlorid gereinigt wird. Man erhält 30 Ge wichtsteile reines Cyclohexylamino-acet- (2 chlor-6-methyl-anilid). Die Umsetzung mit Cyelohexylamin kann auch in Benzol stattfinden. After the ethereal solution has dried and the solvent has been driven off, an oil remains which is purified by converting it into the hydrochloride. 30 parts by weight of pure cyclohexylamino-acet- (2 chloro-6-methyl-anilide) are obtained. The reaction with cyelohexylamine can also take place in benzene. PATENTANSPRUCH : Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure- (2-halogen-6- methyl-anilids), dadurch gekennzeiehnet, dass man eine Verbindung der Formel EMI1.2 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, nit Cyclohexylamin umsetzt. Das auf diese iVeise erhaltene Cyclohexylamino-acet- (2chlor-6-methyl-anilid) bildet ein farbloses öl Das Hydrochlorid der Base schmilzt bei 231 bis 233¯. PATENT CLAIM: Process for the preparation of a new basic substituted fatty acid (2-halogen-6-methyl-anilide), characterized in that a compound of the formula EMI1.2 in which X is a reactive radical which is split off during the reaction, reacts with cyclohexylamine. The cyclohexylamino-acet- (2-chloro-6-methyl-anilide) obtained in this way forms a colorless oil. The hydrochloride of the base melts at 231 to 233 ′. Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt Verwendung finden. The new anilide will be used as a local anesthetic and as an intermediate product. UNTERANSPRUCH : Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man ein Halogenacet- (2- chlor-6-methyl-anilid) mit Cyelohexylamin reagieren lϯt. SUBClaim: Process according to patent claim, characterized in that a halogen acet (2-chloro-6-methyl-anilide) is allowed to react with cyelohexylamine.
CH311612D 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). CH311612A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311612T 1952-02-25
CH307799T 1952-11-25

Publications (1)

Publication Number Publication Date
CH311612A true CH311612A (en) 1955-11-30

Family

ID=25735345

Family Applications (1)

Application Number Title Priority Date Filing Date
CH311612D CH311612A (en) 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Country Status (1)

Country Link
CH (1) CH311612A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11512058B2 (en) 2019-03-11 2022-11-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11643404B2 (en) 2019-03-11 2023-05-09 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11603355B2 (en) 2019-03-11 2023-03-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11696912B2 (en) 2019-11-06 2023-07-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Similar Documents

Publication Publication Date Title
CH421078A (en) Process for the preparation of aminoacetylene compounds
CH311612A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311613A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311606A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311610A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311614A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311608A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311609A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311607A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311615A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311611A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311644A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311632A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311642A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311631A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311629A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311605A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311603A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311624A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311604A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311639A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH312572A (en) Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide
CH311630A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311619A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311633A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).